SummerHaven Investment Management LLC Purchases 1,028 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

SummerHaven Investment Management LLC boosted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 0.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 112,327 shares of the company’s stock after acquiring an additional 1,028 shares during the quarter. Pediatrix Medical Group comprises about 1.1% of SummerHaven Investment Management LLC’s investment portfolio, making the stock its biggest holding. SummerHaven Investment Management LLC owned 0.13% of Pediatrix Medical Group worth $1,628,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Pediatrix Medical Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock worth $141,861,000 after purchasing an additional 113,976 shares during the period. Boston Partners lifted its position in Pediatrix Medical Group by 25.2% in the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock worth $25,922,000 after buying an additional 393,600 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Pediatrix Medical Group by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock valued at $25,562,000 after buying an additional 11,045 shares during the period. American Century Companies Inc. grew its holdings in shares of Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after acquiring an additional 1,500,485 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of Pediatrix Medical Group by 18.0% in the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company’s stock worth $12,678,000 after acquiring an additional 147,522 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on MD shares. Macquarie boosted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Thursday, May 8th. UBS Group cut their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research report on Monday, May 12th. Finally, Truist Financial decreased their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $16.67.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $14.22 on Thursday. The business’s 50-day simple moving average is $13.65 and its 200-day simple moving average is $14.00. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -11.85, a P/E/G ratio of 1.74 and a beta of 1.27.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. During the same quarter last year, the firm posted $0.20 earnings per share. The company’s quarterly revenue was down 7.4% compared to the same quarter last year. As a group, equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.